drugset / Trial / NCT06775327

Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, & Food Effect of Oral INCB000631 to Healthy Adult Participants

NCT06775327 ↗

Phase 1 Completed 71 enrolled Incyte Corporation
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will be conducted to assess the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics, and Food Effect of INCB000631 When Administered Orally to Healthy Adult Participants.

Timeline

Start
2025-02-13
Primary completion
2025-05-28
Completion
2025-05-28

Drugs

EvaluationDrugModalityDoseRoute
Subject INCB000631 Unknown — Oral

Indications

No indication recorded.